Download presentation
Presentation is loading. Please wait.
1
A Better Solution For Cancer Patients With VTE?
3
Program Goals
4
Cancer and VTE - Epidemiology
5
Warfarin in Managing Cancer-Associated VTE
6
CLOT - A Landmark Study for Treatment of Cancer-Associated Thrombosis
7
LMWH vs VKA in Patients With Cancer: Efficacy (Recurrent VTE) and Safety (Major Bleeding)
8
Guideline Recommendations Treatment and Secondary Prophylaxis of Cancer-Associated VTE
9
Subgroup Analysis of Patients With Active Cancer: Efficacy and Safety of NOACs vs VKA
10
US Prescription Patterns for Cancer-Associated VTE
11
LMWH vs VKAs
12
Hokusai VTE Cancer − Study Design
13
Hokusai VTE Cancer: Clinical Outcomes
14
Hokusai VTE-Cancer: Types of Major Bleeds Contributing to Primary Outcome
15
Clinical Implications of Hokusai VTE Cancer
16
Adherence to VTE therapy
17
On-Treatment Analysis in Hokusai VTE Cancer
18
Hokusai VTE Cancer: Cumulative Event Rate for Primary Endpoint
19
Issue of Bleeding in Hokusai VTE Cancer
20
Select-D Pilot Trial
21
Summary
22
Abbreviations
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.